Keyphrases
Major Depressive Disorder
100%
Antidepressants
100%
Triple Reuptake Inhibitor
100%
Monoamine Hypothesis
100%
Melancholic Depression
50%
Atypical Depression
50%
Motivation
25%
Monoamines
25%
Dopamine Level
25%
Reuptake
25%
New Drugs
25%
Neurotoxicity
25%
Area Cover
25%
Mental Illness
25%
Selective Serotonin Reuptake Inhibitors
25%
Dopaminergic Neurotransmission
25%
Neurotransmitter Systems
25%
Depression Level
25%
Expert Opinion
25%
Pharmacological Treatment
25%
Brain Dysfunction
25%
Neuroprotective Potential
25%
Novel Antidepressant
25%
Cause of Disability
25%
Residual Symptoms
25%
Brain Abnormalities
25%
Distinct Subtypes
25%
Serotonin-noradrenaline Reuptake Inhibitor
25%
Medicine and Dentistry
Antidepressant
100%
Serotonin-Norepinephrine-Dopamine Reuptake Inhibitor
100%
Major Depressive Episode
100%
Monoamine
100%
Melancholia
50%
Atypical Depression
50%
Drug Therapy
25%
Disease
25%
Symptom
25%
Neurotransmission
25%
Neurotransmitter
25%
Reuptake Inhibitor
25%
Excitotoxicity
25%
Brain Abnormalities
25%
Neuroprotective Agent
25%
Serotonin
25%
Norepinephrine Reuptake Inhibitor
25%
Pharmacology, Toxicology and Pharmaceutical Science
Serotonin-Norepinephrine-Dopamine Reuptake Inhibitor
100%
Monoamine
100%
Major Depression
100%
Antidepressant
75%
Atypical Depression
50%
Melancholia
50%
Norepinephrine Reuptake Inhibitor
25%
Antidepressant
25%
Reuptake Inhibitor
25%
Dopamine Receptor Stimulating Agent
25%
Excitotoxicity
25%
Neurotransmitter
25%
Symptom
25%
Disease
25%
Neuroprotective Agent
25%
Serotonin
25%